Alzheimer's amyloid-ß rescues yeast from hydroxide toxicity

QR Code

Alzheimer's amyloid-ß rescues yeast from hydroxide toxicity

Amyloid-ß (Aß-{42}), which is known to be toxic to neuronal cells, protects yeast cells from severe sodium hydroxide toxicity. More than 85% cell death was caused by treatment with 1 mM NaOH and approximately 95% was observed at a 2 mM concentration. However, greater than 55% cells survived the trea...

Full description

Bibliographic Details
Main Authors:	Dubey, A., Bharadwaj, Prashant, Varghese, J., MacReadie, I.
Format:	Journal Article
Published:	IOS Press 2009
Online Access:	http://hdl.handle.net/20.500.11937/42488

Similar Items

Finding chemopreventatives to reduce amyloid beta in yeast
by: Macreadie, I., et al.
Published: (2016)

Yeast as a model for studying Alzheimer's disease
by: Bharadwaj, Prashant, et al.
Published: (2010)

A yeast model for studying intracellular clearance of beta-amyloid 42
by: Bharadwaj, Prashant, et al.
Published: (2012)

The Effects of Latrepirdine on Amyloid-ß Aggregation and Toxicity
by: Porter, T., et al.
Published: (2016)

Modulation of amyloid-ß 1-42 structure and toxicity by proline-rich whey peptides
by: Bharadwaj, Prashant, et al.
Published: (2013)

Aß aggregation and possible implications in Alzheimer's disease pathogenesis
by: Bharadwaj, Prashant, et al.
Published: (2009)

Amyloid-ß and islet amyloid pathologies link Alzheimer disease and type 2 diabetes in a transgenic model.
by: Wijesekara, N., et al.
Published: (2017)

Role of the cell membrane interface in modulating production and uptake of Alzheimer's beta amyloid protein
by: Bharadwaj, Prashant, et al.
Published: (2018)

The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-ß, Amylin, and Tau Proteins
by: Bharadwaj, Prashant, et al.
Published: (2017)

Modulation of Amyloid Beta (Aß) Structure and Toxicity by a Dairy-derived Peptide Product
by: Bennett, L., et al.
Published: (2010)

Autoantibody-catalyzed hydrolysis of amyloid ß peptide
by: Taguchi, H., et al.
Published: (2008)

Oligomerization and toxicity of Aß fusion proteins
by: Caine, J., et al.
Published: (2011)

Ovariectomy and 17ß-estradiol replacement do not alter ß-amyloid levels in sheep brain
by: Barron, A., et al.
Published: (2009)

Distinct Effects of Testosterone on Plasma and Cerebrospinal Fluid Amyloid-ß Levels
by: Wahjoepramono, E., et al.
Published: (2008)

Enterocyte Beta Amyloid-Lipoprotein Homeostasis: Implications for Alzheimer's Disease Risk
by: Galloway, Susan
Published: (2015)

The Role of Presenilin and its Interacting Proteins in the Biogenesis of Alzheimer’s Beta Amyloid
by: Verdile, Giuseppe, et al.
Published: (2007)

Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor
by: Xie, Ling, et al.
Published: (2002)

Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study
by: Pike, K., et al.
Published: (2011)

Plasma lipoprotein b-amyloid in subjects with Alzheimer's disease or mild cognitive impairment
by: Mamo, John, et al.
Published: (2008)

Characterisation of the structure and oligomerisation of islet amyloid polypeptides (IAPP): A review of molecular dynamics simulation studies
by: Moore, S., et al.
Published: (2018)

Plasma Amyloid-beta as a Biomarker in Alzheimer's Disease: The AIBL Study of Aging
by: Lui, J., et al.
Published: (2010)

Amyloid ß–associated cognitive decline in the absence of clinical disease progression and systemic illness
by: Harrington, K., et al.
Published: (2017)

Associations between gonadotropins, testosterone and [beta] amyloid in men at risk of Alzheimer’s disease
by: Verdile, Giuseppe, et al.
Published: (2014)

Molecular docking studies on the interaction of anti-alzheimer compounds with amyloid beta peptides
by: Faujan, Nur Hana, et al.
Published: (2019)

Effect of fatty acids on enterocytic beta-amyloid abundance: Possible aetiology in Alzheimer’s disease
by: Galloway, S., et al.
Published: (2008)

Association of Cardiovascular Factors and Alzheimer's Disease Plasma Amyloid-beta Protein in Subjective Memory Complainers
by: bates, K., et al.
Published: (2009)

Clearance mechanisms of Alzheimer’s amyloid-b peptide: implications for therapeutic design and diagnostic tests
by: Bates, K., et al.
Published: (2009)

Clearing the amyloid in Alzheimer's: progress towards earlier diagnosis and effective treatments - an update for clinicians.
by: Asih, P., et al.
Published: (2014)

The effect of Thymosine-ß4 on macrophage phenotype in Alzheimer’s disease
by: Hussain, Ikra
Published: (2019)

Luteinizing Hormone Levels Are Positively Correlated with Plasma Amyloid-ß Protein Levels in Elderly Men
by: Verdile, Giuseppe, et al.
Published: (2008)

ß-Amyloid, APOE and BDNF Genotype, and Depressive and Anxiety Symptoms in Cognitively Normal Older Women and Men
by: Holmes, S., et al.
Published: (2016)

Multitarget drug design strategy in Alzheimer’s disease: focus on cholinergic transmission and amyloid-β aggregation
by: Simioni, Elena, et al.
Published: (2017)

Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies
by: Martins, R., et al.
Published: (2018)

Screening exons 16 and 17 of the amyloid precursor protein gene in sporadic early-onset Alzheimer’s disease
by: Barber, Imelda S., et al.
Published: (2016)

Screening exon 16 and 17 of the amyloid precursor protein gene in sporadic early-onset Alzheimer's disease
by: Barber, Imelda S., et al.
Published: (2016)

Interactive Effects of Dietary Fat and APOE Genotype on Peripheral Amyloid-Beta: Implications for Alzheimer’s Disease Risk
by: D'Alonzo, Zachary John
Published: (2025)

Unveiling amyloid-β1–42 interaction with zinc in water and mixed hexafluoroisopropanol solution in Alzheimer’s disease
by: Ghani, Nur Syafiqah Abdul, et al.
Published: (2017)

Latrepirdine enhances Aß degradation in yeast via an autophagic pathway
by: Bharadwaj, Prashant, et al.
Published: (2010)

Colocalisation of plasma derived apo B lipoproteins with cerebral proteoglycans in a transgenic-amyloid model of Alzheimer's disease
by: Lam, Virginie, et al.
Published: (2011)

The who, when, why, and how of PET Amyloid imaging in management of Alzheimer’s disease-review of literature and interesting images
by: Suppiah, Subapriya, et al.
Published: (2019)

Cannot write session to /tmp/vufind_sessions/sess_g9ju385cva6suct91o7rl5nnj3